ライフサイエンスコーパス: incarceration

1 lcohol abuse, intimate partner violence, and incarceration).

2 unfavorable life experiences (e.g., frequent incarcerations).

3 icipants at 1 month after their release from incarceration.

4 longer following sustained treatment versus incarceration.

5 there are transmission networks that precede incarceration.

6 drugs (PWID), many of whom have a history of incarceration.

7 e to women who did not have a parent undergo incarceration.

8 the relation between depression and parental incarceration.

9 ering posttreatment arrest rates and days of incarceration.

10 me-from immigration to public health to mass incarceration.

11 ss is a risk factor for multiple episodes of incarceration.

12 Inmates often lack health care before incarceration.

13 ropositivity was associated with tattoos and incarceration.

14 ry of reported frequency of injection and of incarceration.

15 (5) have fewer episodes of homelessness and incarceration.

16 used to determine independent predictors of incarceration.

17 e, and 38 percent of those with a history of incarceration.

18 , foreign birth, homelessness, or history of incarceration.

19 parents had histories of substance abuse or incarceration.

20 , or instability from parental separation or incarceration.

21 f cancer care among people with a history of incarceration.

22 2019 implementation of buprenorphine during incarceration.

23 RD), choroidal detachment, and vitreoretinal incarceration.

24 vey waves assessing self-reported history of incarceration.

25 transmission networks for MRSA that precede incarceration.

26 at high risk for loss to follow-up by way of incarceration.

27 sing, and 57.9% (50.5-65.2) had a history of incarceration.

28 n is a cornerstone of efforts to reduce mass incarceration.

29 e mortality, homelessness, violent crime and incarceration.

30 ere are MRSA transmission networks preceding incarceration.

31 s resulted in extraordinarily high levels of incarceration.

32 cases in people who inject drugs are due to incarceration.

33 kely than those without to have had previous incarcerations.

34 9), receipt of antiretroviral therapy during incarceration (1.39; 1.11-1.74), and two or more medical

35 ivity was particularly low for vitreoretinal incarceration (11%), RT (32%), and RD (78%).

36 atient, >1 sex partner, illicit drug use, or incarceration (21% of cases versus 4% of controls expose

37 ys after injury, included RD without retinal incarceration (39%), RD with retinal incarceration in th

38 fied 3,127 deaths of individuals with recent incarceration (705 in detention and 2,422 following rele

39 Cases more often had a history of incarceration (71.4% versus 37.5%, p = 0.09).

40 There were 800 incarcerations (718 individuals) enrolled; 58% were HIV-

41 men receiving 9H-SAT, men with a history of incarceration, alcohol abuse, use ever of intravenous dr

42 imizing detrimental outcomes associated with incarceration among nonincarcerated family members.

43 0 adults who had experienced at least 1 jail incarceration and 1 homeless shelter stay in 2001-2003 i

44 identified 130 new TB cases diagnosed during incarceration and 170 among individuals released from pr

45 d States has experienced an enormous rise in incarceration and accompanying increases in returning pr

46 in the US, the association between parental incarceration and cardiovascular risk remains poorly und

47 Associations between jail incarceration and cause-specific mortality rates weakene

48 f deaths unlikely to occur in the context of incarceration and compassionate releases of moribund pat

49 ties are disproportionately affected by both incarceration and COVID-19.

50 was not associated with rejection likelihood.Incarceration and criminal history significantly reduce

51 me populations experience both high rates of incarceration and high rates of sexually transmitted inf

52 interventions to reduce recurrent cycles of incarceration and homelessness are needed to augment beh

53 People experiencing incarceration and homelessness represent additional key

54 aracterized by sporadic experiences of brief incarceration and homelessness, whereas the rest had the

55 Such programs can reduce incarceration and its associated costs, and also avert o

56 assembly (supramolecular wrapping, nanoscale incarceration and nanostructure templating) or higher-or

57 on correlation coefficients between rates of incarceration and of reportable STIs in the 100 counties

58 nted to remain on methadone treatment during incarceration and on release, to either continuation of

59 prisoners health and reduce risk throughout incarceration and on release.

60 Associations between childhood parental incarceration and other diagnoses (ie, obesity, hyperlip

61 Associations between recent incarceration and outcomes were examined using modified

62 research has examined links between parental incarceration and physical health.

63 rsonality disorder are especially at risk of incarceration and readmission into compulsory treatment

64 age to HIV and substance use services during incarceration and reentry.

65 We then used Scottish data on incarceration and regional prevalence of injecting drug

66 erated populations, to examine the impact of incarceration and release from prison on HIV risk behavi

67 s the TB risk for prisoners as they traverse incarceration and release, (2) mathematically models the

68 The correlations between rates of incarceration and reported cases of acquired immunodefic

69 that address the precursors to family member incarceration and seek to minimize family member incarce

70 principles and thus alter justification for incarceration and sentence completion.

71 d practices that could mitigate the harms of incarceration and the post-incarceration period is urgen

72 timated the incidence of TB from the time of incarceration and the time of prison release using Cox p

73 ntenance-treatment clinic after release from incarceration and time to engagement with methadone main

74 red the spread of HIV and HCV infections and incarceration and treatment systems as well as preexisti

75 ajor negative life outcomes, including adult incarceration and unemployment.

76 ess, noninjection drug use, and a history of incarceration and/or cavitary disease were predictors of

77 ID population, associated with homelessness, incarceration, and a major shift to injection of cocaine

78 health treatment, subjective general health, incarceration, and bankruptcy.

79 or nonopioid prescriptions, medical history, incarceration, and demographics as strong predictors.

80 access to HIV drugs, threats of violence or incarceration, and few targeted HIV prevention resources

81 previous treatment for TB, had a history of incarceration, and had poor outcomes.

82 d homelessness or unstable housing, previous incarceration, and hepatitis C virus exposure.

83 n by income, reduced economic mobility, mass incarceration, and increased exposure to the costs of me

84 find that exposure to neighborhood violence, incarceration, and lead combine to independently predict

85 se characterized by high levels of violence, incarceration, and lead exposure.

86 fewer persons experiencing homelessness and incarceration, and more persons with health insurance an

87 ssociation between reduced household income, incarceration, and mortality from drug use disorders wit

88 nsfusion, prior tattoo, combat medical work, incarceration, and multiple opposite sex partners.

89 ties, and the health effects of racism, mass incarceration, and the Affordable Care Act (ACA).

90 nsitivity predicted a higher number of prior incarcerations, and moderated the relationship between p

91 usehold substance abuse, mental illness, and incarceration; and parental domestic violence, separatio

92 Compared with respondents with no family incarceration, any family member incarceration was assoc

93 nity-dwelling older adults with a history of incarceration are also at risk for worse health outcomes

94 essful events such as systemic illnesses and incarceration are also detectable.

95 sures to screen for active tuberculosis upon incarceration are important for preventing spread of dis

96 Individuals with a history of incarceration are more likely to be of racial and ethnic

97 onization, and prior exposure to hospital or incarceration are significant factors.

98 5% CI, .21-.98]; P = .044), and highest with incarceration (ARR, 1.43 [95% CI, 1.08-1.89]; P = .013)

99 transmission model among PWID incorporating incarceration, ART, and opioid agonist therapy was calib

100 The magnitude of incarceration as a major force in American society, its

101 independently predict poor black boys' later incarceration as adults and lower income rank relative t

102 buse/dependence, depression, bankruptcy, and incarceration associated with recreational gambling.

103 l was 1 day; the median length of continuous incarceration before diagnosis of tuberculosis in inmate

104 ncrease in explained variance for black male incarceration beyond that of concentrated poverty and ot

105 Among those with any family incarceration, Black respondents had a mean (SE) estimat

106 ion of networks of individuals released from incarceration, both HIV positive and negative, is needed

107 duction in prison admissions and duration of incarceration by 2034 would reduce population tuberculos

108 Incarceration can represent a unique opportunity to make

109 colonized individual with current or recent incarceration carried USA300.

110 ore likely to have had four or more previous incarcerations compared with inmates who had no major ps

111 020-40; 74.8-95.8% of these total costs were incarceration costs.

112 020-40; 74.8-95.8% of these total costs were incarceration costs.

113 Continuation of methadone maintenance during incarceration could contribute to greater treatment enga

114 ated men, and raises concerns that excessive incarceration could harm entire communities and thus mig

115 ormer inmates, with findings suggesting that incarceration could produce some short-term improvements

116 fared the worst, with lives characterized by incarceration, criminal activity, and few positive outco

117 We obtained individual-level incarceration data for all inmates (n = 42,925) and all

118 sus Bureau, and county-level jail and prison incarceration data from the Vera Institute of Justice fo

119 31, 2019, or their date of death, and county incarceration data from the Vera Institute of Justice.

120 st-18-month arrests, and fewer post-18-month incarceration days than the TAU group.

121 pants include lower pre-18-month arrests and incarceration days, treatment at baseline, not using ill

122 Cycles of incarceration, drug abuse, and poverty undermine ongoing

123 ys of release are intermediate (31-364 days) incarceration duration (adjusted odds ratio 1.52; 95% CI

124 The risk of incarceration during nonoperative management (NOM) facto

125 Although incarceration during pregnancy is both stressful and deh

126 ot translate to reduced rates of rearrest or incarceration during the 12-month study period.

127 ore than 600,000 prisoners are released from incarceration each year in the United States, and most e

128 There were 718 individuals (800 incarcerations) enrolled; 58% were PLHIV.

129 ing the excess morbidity and mortality of an incarceration event.

130 viduals who were receiving medication before incarceration, few jails initiated MOUD, and most medica

131 Although fee relief reduced incarceration, financial sanctions had no effect on indi

132 a large reduction in the prevalence of jail incarceration for Black and Latino men.

133 demographic characteristics, and history of incarceration for the preceding 6-year period were obtai

134 with additional 9.5% urine refusal and 14.0% incarceration, for whom urinalyses were unavailable), 66

135 Further, we found that incarceration from missed court dates dropped by a simil

136 nd 365 days were significantly higher in the incarceration group at 7.2%, 10%, and 14% versus 1.1%, 2

137 ry, and communities:(1) whether and how mass incarceration has affected the social and economic struc

138 waves II and IV, women experiencing parental incarceration have a 0.92-unit increase in body mass ind

139 Drug use and incarceration have a substantial impact on rural communi

140 hic factors, social support, housing status, incarceration history, chronic medical conditions, subst

141 nitiation rates are strongly associated with incarceration history, so that our analysis of IDUs' rep

142 ted the relationship between psychopathy and incarceration history.

143 Community exposures (eg, substance abuse, incarceration, homelessness) were associated with HACO a

144 as determined from episodes of homelessness, incarceration, hospitalization, and residence in support

145 hether through contact with law enforcement, incarceration in a jail or prison, or community supervis

146 for a sexually transmitted disease (STD) or incarceration in a prison or jail prior to their illness

147 ing for Ukraine suggests that high levels of incarceration in EECA countries facilitate HIV transmiss

148 ember 31, 2019, on individuals released from incarceration in RI and NC.

149 retinal incarceration (39%), RD with retinal incarceration in the scleral or corneal wound or both (1

150 The United States has the highest rate of incarceration in the world.

151 Independent variables associated with incarceration included: age older than 40 years, female

152 causes of the stronger associations included incarceration increasing the number of infected prisoner

153 ndex for women who have experienced parental incarceration is 0.49 units (P < 0.004) higher than that

154 HCV treatment during incarceration is an attractive option because of improve

155 Incarceration is an uncommon complication of NOM but is

156 tress, the authors examined whether parental incarceration is associated with increased body mass ind

157 Although incarceration is associated with worse cancer outcomes,

158 Incarceration is justified on 4 principles: retribution,

159 First, family member incarceration is now common for American families.

160 Interventions that reduce incarceration itself and effectively intervene with pris

161 th of African Americans, experience parental incarceration, little research has examined links betwee

162 ceration neighborhoods, suggesting that mass incarceration may contribute to racial disparities in bi

163 on to their potential for reducing crime and incarceration, may have implications for both management

164 462 participants, 946 (7.6%) had experienced incarceration (mean [SD] age, 62.4 [7.8] years); compare

165 ); compared with 12 516 people with no prior incarceration (mean [SD] age, 66.7 [10.0] years), previo

166 o December 2019 were collected from juvenile incarceration, Medicaid, and death certificate informati

167 In the coastal region, history of incarceration, more years injecting, more injections in

168 most common criminalisation indicators were incarceration (n=38) and street-level policing (n=39), w

169 al histories containing the following HRSBs: incarceration (n=69), unprofessional tattoos or piercing

170 The primary outcome was incarceration necessitating emergent operation.

171 45 people incarcerated per 100 000, and high-incarceration neighborhoods had more residents of Black

172 re significantly more likely to live in high-incarceration neighborhoods, suggesting that mass incarc

173 ivalent (28.00% vs 12.00%) compared with low-incarceration neighborhoods.

174 t can cause continuing court involvement and incarceration, not because of new crimes, but because of

175 mptoms increase is safe because acute hernia incarcerations occur rarely.

176 ed recent incarceration, with a median (IQR) incarceration of 15 (3-60) days in the past 6 months.

177 The median length of incarceration of all inmates in the jail was 1 day; the

178 he Affordable Care Act; (3) disproportionate incarceration of BIPOC into crowded prisons with low tub

179 the Affordable Care Act;(3) disproportionate incarceration of BIPOC into crowded prisons with low tub

180 aim of the study was to quantify the risk of incarceration of incisional hernias.

181 s and the broader community is to reduce the incarceration of people who inject drugs.

182 communities, but factors associated with the incarceration of rural people who use drugs (PWUD) have

183 he acquired cases, all but one resulted from incarceration of the tendon from postsurgical scar tissu

184 ect of forced withdrawal from methadone upon incarceration on individuals' risk behaviours and engage

185 releases eliminated the protective effect of incarceration on mortality.

186 and the negative influences of high rates of incarceration on social disorganization and collective e

187 ive technologies, and the effect of parental incarcerations on families.

188 Current levels of incarceration, opioid agonist therapy, and ART were esti

189 Current levels of incarceration, opioid agonist therapy, and ART were esti

190 ence of subretinal hemorrhage and no retinal incarceration or loss of vitreous.

191 On multivariate analysis, history of incarceration or residence in alternative housing (odds

192 e 1991 (OR = 3.21; 95% CI = 1.02-10.12), and incarceration (OR = 3.48; 95% CI = 1.45-8.37).

193 risk (eg, unemployment, low income, previous incarceration, or less education) compared with other US

194 ace, foreign birth, homelessness, history of incarceration, or prior tuberculosis.

195 ms of the presence of negative consequences (incarceration, or readmission to compulsory treatment, o

196 er (OR, 2.68; 95% CI, 1.25-5.60), history of incarceration over 48 hours (OR, 2.56; 95% CI, 1.52-4.32

197 ad substantially increased risks of multiple incarcerations over the 6-year study period.

198 (P = 0.035), legal troubles (P = 0.002), and incarceration (P = 0.007) in unadjusted analyses and wit

199 ation of ART, year of discharge, duration of incarceration, parole, and AIDS Drug Assistance Program

200 As the era of mass incarceration peaks, we argue that the time is ripe for

201 gate the harms of incarceration and the post-incarceration period is urgently needed, particularly st

202 Among 3302 incarceration periods for 1350 individuals between 2007

203 lease and reincarceration, the proportion of incarceration periods with viral suppression decreased s

204 etween drug-related mortality and income and incarceration persisted after controlling for local opio

205 on the family and community effects of mass incarceration points to negative health impacts on the f

206 Arrest and incarceration policies appear to be increasing COVID-19

207 etes, hypertension, asthma, and a history of incarceration presented to a free clinic with acute exac

208 juvenile delinquency, adult criminality, and incarceration prior to the time of spinal cord injury.

209 relevant incarceration-related keywords (eg, incarceration, prison, parole) since January 1, 1985 (NI

210 ses on two complementary questions regarding incarceration, prisoner reentry, and communities:(1) whe

211 In the absence of alternatives to incarceration, prisons and detention facilities could be

212 ated to probation, parole, or alternative-to-incarceration programs in New York City who had a histor

213 sidering the aforementioned risk factors for incarceration provides an initial step toward mitigating

214 Incarceration provides an opportunity for engagement in

215 d to examine the association of neighborhood incarceration rate and birth outcomes.

216 ilable in prisons-despite the country's high incarceration rate and having the largest burden of peop

217 Our model indicates that decreasing the incarceration rate in people who inject drugs and provid

218 A 1 per 1000 within-county increase in jail incarceration rate was associated with a 6.5% increase i

219 creased from 6258 in 2009 to 14,627 in 2018 (incarceration rate, 101 to 207 per 100,000 persons) whil

220 Although New York has a low jail incarceration rate, we find that 26.8% of Black men and

221 n Americans--the population with the highest incarceration rates and chlamydia burden (small communit

222 ion has led to disproportionately high Black incarceration rates and countless Black deaths.

223 County jail incarceration rates are associated with all-cause mortal

224 hough many studies have documented that high incarceration rates are associated with communitywide he

225 Reduced household income and high incarceration rates are associated with poor health.

226 area within criminology that stalled just as incarceration rates dramatically climbed.

227 we have first to estimate piecewise constant incarceration rates in conjunction with EFR initiation r

228 g developments as a case study, we find that incarceration rates in NYCHA tracts are 4.6 times higher

229 Compared with a scenario where incarceration rates remain stable at current levels, a g

230 As incarceration rates rise globally, the need to reduce re

231 mong 2061 Census tracts with 562 339 births, incarceration rates varied from 0 to 4545 people incarce

232 A 10% increase in county jail incarceration rates was associated with 4.6 (95% CI, 3.8

233 Each 1 SD increase in jail and prison incarceration rates was associated with an increase of 1

234 Higher incarceration rates were associated with lower prison su

235 e the associations between economic decline, incarceration rates, and age-standardised mortality from

236 tions with general population suicide rates, incarceration rates, and prison-related factors (overcro

237 use in the community, ratio of men to women, incarceration rates, and racial segregation, influence s

238 However, tight states also have higher incarceration rates, greater discrimination and inequali

239 Despite rapidly rising incarceration rates, the health needs of women in custod

240 enses and in line with average international incarceration rates, would have been associated with a 2

241 hlamydia prevalence in communities with high incarceration rates.

242 wed that forced withdrawal from methadone on incarceration reduced the likelihood of prisoners re-eng

243 ical project archives to search for relevant incarceration-related keywords (eg, incarceration, priso

244 Existing studies of incarceration-related mortality are limited by data sour

245 ICIPANTS: A cohort study was conducted using incarceration release data from January 1, 2009, to Dece

246 he person's community supervision, length of incarceration, release type, and calendar year on the ha

247 Weaker associations with incarceration, religious scarification, being stuck or c

248 and surgeon; however, the incidence of acute incarceration remains largely unknown.

249 After controlling for incarceration, residence, and geography, HIV status was

250 of age, sex, race or ethnicity, whether the incarceration resulted from a violation of terms of the

251 Exposure to hypothetical scarcity during incarceration resulted in reduced cognitive persistence

252 w-up, HCV incidences per 100 person-years of incarceration risk were 1, 12, 19, and 27, respectively.

253 An estimate of incarceration's financial burden reveals that families c

254 In this Series paper, we examine how mass incarceration shapes inequality in health.

255 , 1.7-5.0; p<0.0001), had had more than five incarcerations since they first began injecting (2.1, 1.

256 Including savings from reduced incarceration (societal perspective) improved the ICER t

257 Incarceration status was not a significant predictor whe

258 analysis examining if gender differences in incarceration stress response (externalizing vs. interna

259 potential for complications such as retinal incarceration, subretinal hemorrhage, and loss of vitreo

260 er educational level, poverty, homelessness, incarceration, substance use, binge alcohol use, depress

261 risk factors for infection, ill-health, and incarceration, such as problem drug use.

262 red by traffic incidents, criminal behavior, incarceration, suicide attempts, and comorbidities.

263 risk of serious medical and legal problems, incarceration, suicide, school difficulties and dropout,

264 dy used data from the 2018 Family History of Incarceration Survey to examine how experiences of famil

265 treatment data collected at the time of each incarceration, the incidence of syphilis infection among

266 for 1 week at the dose at the time of their incarceration, then a tapered withdrawal regimen (for th

267 f these factors were likely present prior to incarceration, they may help medical staff identify pris

268 Compared with those with no history of incarceration, those diagnosed with cancer during incarc

269 a compartmental model of TB transmission and incarceration to evaluate the effects of various prison-

270 a pernicious "feedback" loop, in which mass incarceration undermines the structure and social organi

271 Previous or current incarceration was also associated with a higher risk for

272 tainment, and uninsured status, a history of incarceration was associated with a 20% to 80% increased

273 h no family incarceration, any family member incarceration was associated with lower well-being overa

274 Among women who used heroin living with HIV, incarceration was associated with stopping HIV care (9 o

275 Mortality during incarceration was low (SMR = 0.85, 95% CI: 0.77, 0.94),

276 ithin one month; this dropped to 26.2% after incarceration was mentioned.

277 history of substance abuse, homelessness, or incarceration, was 1.7%.

278 ingly studied the collateral consequences of incarceration, we know little about the health consequen

279 n 2004 and 2010 and tested HIV positive upon incarceration, we tested their sera using a BED HIV-1 ca

280 to examine how experiences of family member incarceration were associated with a holistic measure of

281 Between counties, high rates of incarceration were associated with a more than 50% incre

282 al control, those with a personal history of incarceration were at greater odds of having an emergenc

283 c costs for opioid agonist therapy, ART, and incarceration were collated or estimated.

284 ceration, those diagnosed with cancer during incarceration were less likely to initiate treatment wit

285 patients, male sex, younger age, and recent incarceration were positively associated whereas Hispani

286 ently the public health implications of mass incarceration were unclear.

287 The USA is the world leader in incarceration, which disproportionately affects black po

288 to live in neighborhoods with high rates of incarceration, which is a source of both stress and neig

289 ed for 74% of the decreased mortality during incarceration, while 6 causes (human immunodeficiency vi

290 ngulation within 2 years; a second had acute incarceration with bowel obstruction at 4 years, with a

291 ess that, for the first time, links parental incarceration with obesity among women.

292 on their methadone dose at the time of their incarceration (with dose adjustments as clinically indic

293 (if the individual was receiving MOUD before incarceration), with or without initiation of MOUD; (2)

294 of 1224 participants (41.7%) reported recent incarceration, with a median (IQR) incarceration of 15 (

295 ting patient (0.3%) experienced acute hernia incarceration without strangulation within 2 years; a se

296 could be included in the study only if their incarceration would be more than 1 week but less than 6

297 rceration and seek to minimize family member incarceration would best enhance family well-being.

298 pic before summarizing the changes that mass incarceration wrought in correctional contexts and the p

299 underwent NOM of whom 540 (2.3%) experienced incarceration, yielding a 1- and 5-year cumulative incid

300 fferentiating the groups included history of incarceration, young age, participation in drug treatmen